|
1
|
Span PN, Pollakis G, Paxton WA, Sweep FC,
Foekens JA, Martens JW, Sieuwerts AM and van Laarhoven HW: Improved
metastasis-free survival in nonadjuvantly treated postmenopausal
breast cancer patients with chemokine receptor 5 del32 frameshift
mutations. Int J Cancer. 136:91–97. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J,
Cheng L, Fan Z, Yuan B, Tian P, et al: miR-30a suppresses breast
cancer cell proliferation and migration by targeting Eya2. Biochem
Biophys Res Commun. 445:314–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diller M, Schüler S, Buchholz S, Lattrich
C, Treeck O and Ortmann O: Effects of estriol on growth, gene
expression and estrogen response element activation in human breast
cancer cell lines. Maturitas. 77:336–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lenik J: Preparation and characterization
of a sulindac sensor based on PVC/TOA-SUL membrane. Mater Sci Eng C
Mater Biol Appl. 37:383–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giardiello FM, Hamilton SR, Krush AJ,
Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR and
Offerhaus GJ: Treatment of colonic and rectal adenomas with
sulindac in familial adenomatous polyposis. N Engl J Med.
328:1313–1316. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beazer-Barclay Y, Levy DB, Moser AR, Dove
WF, Hamilton SR, Vogelstein B and Kinzler KW: Sulindac suppresses
tumorigenesis in the Min mouse. Carcinogenesis. 17:1757–1760. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahmoud NN, Boolbol SK, Dannenberg AJ,
Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A and
Bertagnolli MM: The sulfide metabolite of sulindac prevents tumors
and restores enterocyte apoptosis in a murine model of familial
adenomatous polyposis. Carcinogenesis. 19:87–91. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piazza GA, Alberts DS, Hixson LJ, Paranka
NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, et al:
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis
in rats without reducing prostaglandin levels. Cancer Res.
57:2909–2915. 1997.PubMed/NCBI
|
|
9
|
Thompson HJ, Jiang C, Lu J, Mehta RG,
Piazza GA, Paranka NS, Pamukcu R and Ahnen DJ: Sulfone metabolite
of sulindac inhibits mammary carcinogenesis. Cancer Res.
57:267–271. 1997.PubMed/NCBI
|
|
10
|
Altuvia Y, Landgraf P, Lithwick G, Elefant
N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H:
Clustering and conservation patterns of human microRNAs. Nucleic
Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YS, Choi D, Kim NY, Yang S, Jung E,
Hong M, Yang D, Lenz HJ and Hong YK: CXCR2 inhibition enhances
sulindac-mediated suppression of colon cancer development. Int J
Cancer. 135:232–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verma R, Brahmankar M, Kushwah L and
Suresh B: Evaluating the inhibitory potential of sulindac against
the bleomycin-induced pulmonary fibrosis in wistar rats. Environ
Toxicol Pharmacol. 36:769–778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liggett JL, Min KW, Smolensky D and Baek
SJ: A novel COX-independent mechanism of sulindac sulfide involves
cleavage of epithelial cell adhesion molecule protein. Exp Cell
Res. 326:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang WW, Ko SW, Tsai HY, Chung JG, Chiang
JH, Chen KT, Chen YC, Chen HY, Chen YF and Yang JS: Cantharidin
induces G2/M phase arrest and apoptosis in human colorectal cancer
cells through inhibition of CDK1 activity and caspase-dependent
signaling pathways. Int J Oncol. 38:1067–1073. 2011.PubMed/NCBI
|
|
15
|
Zhang YT, Ouyang DY, Xu LH, Ji Y, Zha Q,
Cai J and He X: Cucurbitacin B induces rapid depletion of the
G-actin pool through reactive oxygen species-dependent actin
aggregation in melanoma cells. Acta Biochim Biophys Sin (Shanghai).
43:556–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Q, Ouyang DY, Geng M, Xu LH, Zhang
YT, Wang FP and He XH: Valproic acid exhibits biphasic effects on
apoptotic cell death of activated lymphocytes through differential
modulation of multiple signaling pathways. J Immunotoxicol.
8:210–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Greening DW, Ji H, Kapp EA and Simpson RJ:
Sulindac modulates secreted protein expression from LIM1215 colon
carcinoma cells prior to apoptosis. Biochim Biophy Acta.
1834:2293–2307. 2013. View Article : Google Scholar
|
|
18
|
Corbex M, Bouzbid S and Boffetta P:
Features of breast cancer in developing countries, examples from
North-Africa. Eur J Cancer. 50:1808–1818. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Yang AL, Chung YT, Zhang W, Liao J
and Yang GY: Sulindac inhibits pancreatic carcinogenesis in
LSL-Kras G12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing
aldo-keto reductase family 1B10 (AKR1B10). Carcinogenesis.
34:2090–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sinicrope FA and Penington RC: Sulindac
sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2
inhibitor and by TRAIL in human colon cancer cells overexpressing
Bcl-2. Mol Cancer Ther. 4:1475–1483. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim YS, Seol CH, Jung JW, Oh SJ, Hwang KE,
Kim HJ, Jeong ET and Kim HR: Synergistic effect of sulindac and
simvastatin on apoptosis in lung cancer A549 cells through
AKT-dependent downregulation of survivin. Cancer Res Treat.
47:90–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fink SP, Dawson DM, Zhang Y, Kresak A,
Lawrence EG, Yang P, Chen Y, Barnholtz-Sloan JS, Willis JE,
Kopelovich L and Markowitz SD: Sulindac reversal of
15-PGDH-mediated resistance to colon tumor chemo-prevention with
NSAIDs. Carcinogenesis. 36:291–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katoumas KM, Nikitakis N, Perrea D, Dontas
I and Sklavounou A: In vivo antineoplastic effects of the NSAID
sulindac in an oral carcinogenesis model. Cancer Prev Res (Phila).
8:642–649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smalley W, Ray WA, Daugherty J and Griffin
MR: Use of nonsteroidal anti-inflammatory drugs and incidence of
colorectal cancer: A population-based study. Arch Intern Med.
15:161–166. 1999. View Article : Google Scholar
|
